Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Component

  2.3.2 Market Size By Application

  2.3.3 Market Size By AI Technology

  2.3.4 Market Size By End User

 2.3.5 Market Size By Deployment Model

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

   3.4.1 Biomedical data, cloud, AI models, and computing infrastructure providers

3.4.2 AI drug discovery platforms and software solution developers

3.4.3 Technology integrators, CROs, consultants, and research service providers

3.4.4 Pharmaceutical, biotechnology, academic, and contract research organizations

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

  4.1 Platform & Adoption Metrics

4.1.1 Share (%) of AI-enabled drug discovery platforms across machine learning, deep learning, generative AI, and natural language processing technologies.

4.1.2 Growth (%) in AI adoption across pharmaceutical, biotechnology, and contract research organizations during 2025 and 2026.

4.1.3 Increase (%) in AI-assisted target identification, hit discovery, lead optimization, and preclinical research workflows.

4.1.4 Share (%) of drug discovery programs integrating AI across early-stage and late-stage research activities.

4.2 Application & Therapeutic Metrics

4.2.1 Share (%) of AI usage across target identification, molecular screening, de novo drug design, biomarker discovery, and toxicity prediction.

4.2.2 Growth (%) in AI-driven drug discovery across oncology, neurology, infectious diseases, immunology, and rare diseases.

4.2.3 Increase (%) in virtual screening and compound prioritization using predictive modeling.

4.2.4 Share (%) of AI-discovered candidates progressing from computational discovery into preclinical and clinical development.

4.3 R&D & Operational Efficiency Metrics

4.3.1 Increase (%) in R&D productivity through automated data analysis, candidate ranking, and experiment prioritization.

4.3.2 Growth (%) in partnerships between pharmaceutical companies, AI technology providers, and research institutions.

4.3.3 Reduction (%) in discovery timelines, screening costs, failed experiments, and manual research workloads.

4.3.4 Improvement (%) in hit-to-lead conversion, candidate selection accuracy, and experimental success rates.

4.4 Technology & Innovation Metrics

4.4.1 Share (%) of AI drug discovery platforms integrating generative models, knowledge graphs, cloud computing, and high-performance computing.

4.4.2 Growth (%) in foundation models, multimodal AI, and autonomous laboratory technologies for drug discovery.

4.4.3 Increase (%) in integration of genomics, proteomics, structural biology, and real-world data into AI models.

4.4.4 Improvement (%) in molecular prediction accuracy, model interpretability, scalability, and end-to-end drug discovery automation.

5. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By Component, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Software

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Services

6. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Target Identification and Validation

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Molecule Design and Optimization

 6.4 Preclinical Testing

 6.5 Drug Repurposing

 6.6 Others

7. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By AI Technology, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Machine Learning

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Deep Learning

 7.4 Natural Language Processing

 7.5 Generative AI

 7.6 Others

8. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Pharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Biotechnology Companies

 8.4 Contract Research Organizations

 8.5 Academic and Research Institutes

 8.6 Others

9. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By Deployment Model, 2022–2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Cloud-Based 

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022–2035 

  9.3 On-Premise 

  9.4 Hybrid 

10. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Component, 2022–2035

  10.2.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2022–2035

  10.2.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By AI Technology, 2022–2035

  10.2.5 Artificial Intelligence in Drug Discovery Market Size & Forecast, By End User, 2022–2035

  10.2.6 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Deployment Model, 2022–2035

  10.2.7 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Component, 2022–2035

 10.3.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2022–2035

 10.3.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By AI Technology, 2022–2035

 10.3.5 Artificial Intelligence in Drug Discovery Market Size & Forecast, By End User, 2022–2035

 10.3.6 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Deployment Model, 2022–2035

 10.3.7 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Component, 2022–2035

 10.4.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2022–2035

 10.4.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By AI Technology, 2022–2035

 10.4.5 Artificial Intelligence in Drug Discovery Market Size & Forecast, By End User, 2022–2035

 10.4.6 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Deployment Model, 2022–2035

 10.4.7 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Component, 2022–2035

 10.5.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2022–2035

 10.5.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By AI Technology, 2022–2035

 10.5.5 Artificial Intelligence in Drug Discovery Market Size & Forecast, By End User, 2022–2035

 10.5.6 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Deployment Model, 2022–2035

 10.5.7 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Component, 2022–2035

 10.6.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2022–2035

 10.6.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By AI Technology, 2022–2035

 10.6.5 Artificial Intelligence in Drug Discovery Market Size & Forecast, By End User, 2022–2035

 10.6.6 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Deployment Model, 2022–2035

 10.6.7 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 South Africa

  10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Year-Wise Strategies & Development, 2022 – 2026

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

 11.6.1 Isomorphic Labs (Alphabet Inc.)

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

         11.6.1.4 Geographical Presence

  11.6.1.5 SWOT Analysis

 11.6.2 Insilico Medicine

11.6.3 Recursion Pharmaceuticals, Inc.

11.6.4 BenevolentAI

11.6.5 Atomwise, Inc.

11.6.6 Schrodinger, Inc.

11.6.7 Relay Therapeutics, Inc.

11.6.8 Iambic Therapeutics, Inc.

11.6.9 XtalPi Inc.

11.6.10 Valo Health, Inc.

11.6.11 Owkin, Inc.

11.6.12 Insitro, Inc.

11.6.13 Genesis Therapeutics, Inc.

11.6.14 Xaira Therapeutics, Inc.

11.6.15 Generate:Biomedicines, Inc.

11.6.16 Chai Discovery

11.6.17 Terray Therapeutics

11.6.18 Cradle

11.6.19 NVIDIA Corporation

11.6.20 Microsoft Corporation

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures